{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "wsmg:health-sciences:medicine:surgery:vascular:pathology:vasculitis:vasc-016",
  "metadata": {
    "version": "2.1.0",
    "created": "2026-01-08T19:45:00.000Z",
    "modified": "2026-01-09T11:29:00.000Z",
    "contributors": [
      "copilot-agent",
      "vascular-surgery-sme"
    ],
    "confidence": 0.9,
    "status": "enhanced",
    "language": "en",
    "licenses": [
      "CC-BY-4.0"
    ]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vasculitis",
    "subdomain": "anca-associated",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "critical",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "ANCA-Associated Vasculitis",
    "summary": "ANCA-associated vasculitides (AAV) are a group of small-vessel vasculitides characterized by necrotizing inflammation and the presence of anti-neutrophil cytoplasmic antibodies. They include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA).",
    "definition": "A group of necrotizing small-vessel vasculitides associated with anti-neutrophil cytoplasmic antibodies (ANCA), characterized by few or no immune deposits and predominantly affecting small arteries, arterioles, capillaries, and venules",
    "classification": {
      "diseases_included": {
        "GPA": {
          "name": "Granulomatosis with Polyangiitis",
          "note": "Previously known by eponymous name that was changed due to historical concerns",
          "characteristics": [
            "Granulomatous inflammation of respiratory tract",
            "Necrotizing vasculitis of small-medium vessels",
            "Glomerulonephritis"
          ],
          "ANCA_pattern": "PR3-ANCA (c-ANCA) in 75-90%"
        },
        "MPA": {
          "name": "Microscopic polyangiitis",
          "characteristics": [
            "Necrotizing vasculitis with few immune deposits",
            "No granulomatous inflammation",
            "Pauci-immune glomerulonephritis common"
          ],
          "ANCA_pattern": "MPO-ANCA (p-ANCA) in 50-75%"
        },
        "EGPA": {
          "former_name": "Churg-Strauss syndrome",
          "characteristics": [
            "Eosinophil-rich granulomatous inflammation",
            "Asthma and eosinophilia",
            "Small-medium vessel vasculitis"
          ],
          "ANCA_pattern": "MPO-ANCA in 30-50% (less common)"
        }
      }
    },
    "pathophysiology": {
      "ANCA_mechanism": [
        "ANCA binds to primed neutrophils",
        "Causes neutrophil activation and degranulation",
        "Release of reactive oxygen species and proteolytic enzymes",
        "Vascular damage and necrotizing inflammation"
      ],
      "target_antigens": {
        "PR3": "Proteinase 3 (primarily GPA)",
        "MPO": "Myeloperoxidase (primarily MPA, some EGPA)"
      }
    },
    "clinical_manifestations": {
      "systemic": [
        "Fever, malaise, weight loss",
        "Arthralgias, myalgias"
      ],
      "organ_specific": {
        "renal": {
          "frequency": "GPA 80%, MPA 90%",
          "presentation": "Rapidly progressive glomerulonephritis",
          "findings": "Hematuria, proteinuria, rising creatinine"
        },
        "pulmonary": {
          "GPA": "Nodules, cavitary lesions, hemorrhage",
          "MPA": "Alveolar hemorrhage, interstitial fibrosis",
          "EGPA": "Asthma, infiltrates, eosinophilic pneumonia"
        },
        "ENT": {
          "GPA": "Sinusitis, saddle nose, subglottic stenosis",
          "common": "Present in 90% of GPA"
        },
        "cutaneous": {
          "manifestations": [
            "Palpable purpura",
            "Ulcers",
            "Nodules",
            "Livedo"
          ]
        },
        "neurologic": {
          "peripheral": "Mononeuritis multiplex (30-50%)",
          "central": "Rarely affected"
        }
      },
      "vascular_surgery_relevance": {
        "peripheral_ischemia": "Digital ischemia, gangrene from small vessel involvement",
        "aneurysms": "Less common than in polyarteritis nodosa",
        "surgical_considerations": "Poor wound healing, tissue fragility, ongoing inflammation"
      }
    },
    "diagnosis": {
      "laboratory": {
        "ANCA_testing": {
          "methods": [
            "Immunofluorescence (IF)",
            "ELISA for PR3/MPO"
          ],
          "sensitivity": "85-95% in active disease",
          "interpretation": "c-ANCA/PR3 suggests GPA; p-ANCA/MPO suggests MPA"
        },
        "other_labs": [
          "Elevated ESR and CRP",
          "Anemia of chronic disease",
          "Eosinophilia (EGPA)",
          "Urinalysis for RBC casts"
        ]
      },
      "biopsy": {
        "preferred_sites": [
          "Kidney",
          "Lung",
          "Skin",
          "Nerve"
        ],
        "findings": "Necrotizing vasculitis, granulomas (GPA), pauci-immune deposits"
      },
      "imaging": {
        "CT_chest": "Nodules, cavities, ground-glass (hemorrhage)",
        "CT_sinuses": "Mucosal thickening, bone erosion (GPA)"
      }
    },
    "treatment": {
      "induction": {
        "severe_organ_threatening": {
          "glucocorticoids": "High-dose (1mg/kg prednisone or pulse methylpred)",
          "cyclophosphamide": "IV or oral, with rituximab as alternative",
          "rituximab": "Standard alternative, especially for relapsing disease"
        },
        "plasma_exchange": "Consider for severe renal involvement or alveolar hemorrhage"
      },
      "maintenance": {
        "agents": [
          "Azathioprine",
          "Rituximab",
          "Mycophenolate",
          "Methotrexate"
        ],
        "duration": "18-24 months minimum",
        "steroid_taper": "Gradual over 6-12 months"
      },
      "monitoring": {
        "ANCA_titers": "May correlate with disease activity (controversial)",
        "renal_function": "Serial creatinine, urinalysis",
        "imaging": "Periodic chest CT if pulmonary involvement"
      }
    },
    "prognosis": {
      "survival": "5-year survival 80-85% with modern therapy",
      "relapse_rate": "50% relapse within 5 years (GPA > MPA)",
      "ESRD_risk": "20-30% of those with renal involvement",
      "poor_prognostic_factors": [
        "Older age",
        "Severe renal disease at presentation",
        "Pulmonary hemorrhage"
      ]
    },
    "statement": "ANCA-Associated Vasculitis is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Vasculitis that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding ANCA-Associated Vasculitis helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of ANCA-Associated Vasculitis include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of ANCA-Associated Vasculitis."
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "ANCA-Associated Vasculitis"
    },
    "altLabel": [
      {
        "@language": "en",
        "@value": "AAV"
      },
      {
        "@language": "en",
        "@value": "ANCA vasculitis"
      },
      {
        "@language": "en",
        "@value": "Pauci-immune vasculitis"
      }
    ],
    "definition": {
      "@language": "en",
      "@value": "Group of necrotizing small-vessel vasculitides characterized by ANCA antibodies and few immune deposits"
    },
    "notation": "vasc-016"
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/surgery/vascular/pathology/vasculitis",
        "skos:prefLabel": "Vasculitis"
      }
    ],
    "skos:narrower": [
      {
        "@id": "wsmg:health-sciences:medicine:surgery:vascular:pathology:vasculitis:gpa",
        "skos:prefLabel": "Granulomatosis with Polyangiitis"
      },
      {
        "@id": "wsmg:health-sciences:medicine:surgery:vascular:pathology:vasculitis:mpa",
        "skos:prefLabel": "Microscopic Polyangiitis"
      }
    ],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/rheumatology/vasculitis",
        "skos:prefLabel": "Systemic Vasculitis"
      }
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "M31.30",
      "description": "Wegener's granulomatosis without renal involvement"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "239934006",
      "uri": "http://snomed.info/id/239934006",
      "description": "ANCA-associated vasculitis"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Define ANCA-associated vasculitis and list its component diseases",
      "Distinguish GPA, MPA, and EGPA by clinical and serological features",
      "Explain the role of PR3 and MPO antibodies in pathogenesis",
      "Recognize organ manifestations particularly relevant to vascular surgery",
      "Outline induction and maintenance therapy principles"
    ],
    "clinical_pearls": [
      "PR3-ANCA (c-ANCA) = GPA; MPO-ANCA (p-ANCA) = MPA",
      "GPA has upper airway involvement; MPA typically spares it",
      "EGPA has asthma and eosinophilia; ANCA less commonly positive",
      "Rituximab is now standard alternative to cyclophosphamide for induction",
      "50% relapse rate at 5 years - long-term follow-up essential"
    ],
    "estimated_time": "30min",
    "target_audience": [
      "vascular_surgery_residents",
      "rheumatology",
      "nephrology",
      "pulmonology"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). ANCA-Associated Vasculitis. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}